Dermochinona
Brand names,
Dermochinona
Analogs
Dermochinona
Brand Names Mixture
Dermochinona
Chemical_Formula
C21H22N2O5S
Dermochinona
RX_link
http://www.rxlist.com/cgi/generic3/nafcillin.htm
Dermochinona
fda sheet
Dermochinona
msds (material safety sheet)
Dermochinona
Synthesis Reference
No information avaliable
Dermochinona
Molecular Weight
414.476 g/mol
Dermochinona
Melting Point
No information avaliable
Dermochinona
H2O Solubility
Soluble
Dermochinona
State
Solid
Dermochinona
LogP
3.373
Dermochinona
Dosage Forms
Powder for solution
Dermochinona
Indication
For the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drugs.
Dermochinona
Pharmacology
Nafcillin is a semisynthetic antibiotic substance derived from 6-amino-penicillanic acid. The drugs in this class are highly resistant to inactivation by staphylococcal penicillinase and are active against penicillinase-producing and non penicillinase-producing strains of Staphylococcus aureus. The penicillinase- resistant penicillins are active in vitro against a variety of other bacteria.
Dermochinona
Absorption
No information avaliable
Dermochinona
side effects and Toxicity
Serious toxicity is unlikely following large doses of nafcillin. Acute ingestion of large doses of nafcillin may cause nausea, vomiting, diarrhea and abdominal pain. Acute oliguric renal failure and hematuria may occur following large doses.
Dermochinona
Patient Information
Dermochinona
Organisms Affected
Enteric bacteria and other eubacteria